StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
32
This year
3
Publishing Date
2024 - 03 - 21
1
2024 - 02 - 23
1
2024 - 01 - 08
1
2023 - 09 - 19
1
2023 - 07 - 28
1
2023 - 06 - 24
2
2023 - 06 - 22
1
2023 - 04 - 28
1
2023 - 03 - 14
1
2023 - 03 - 04
1
2023 - 02 - 06
1
2023 - 01 - 04
1
2022 - 12 - 22
1
2022 - 11 - 15
1
2022 - 11 - 07
1
2022 - 10 - 17
1
2022 - 10 - 14
1
2022 - 10 - 03
1
2022 - 09 - 22
1
2022 - 08 - 23
1
2022 - 07 - 29
1
2022 - 06 - 20
1
2022 - 06 - 03
1
2022 - 05 - 02
1
2022 - 04 - 28
1
2022 - 03 - 18
1
2022 - 01 - 03
1
2021 - 12 - 20
1
2021 - 11 - 26
1
2021 - 08 - 18
1
2021 - 06 - 21
1
Sector
Health technology
32
Manufacturing
3
Tags
Acquire
7
Agreement
5
Application
6
Approval
7
Biotech
7
Biotechnology
5
Bleeding
7
Blood
5
Cancer
6
Cardiovascular
5
Collaboration
8
Companies
6
Conference
20
Device
5
Diabetes
34
Disease
18
Drug
18
Earnings
8
Europe
10
Events
22
Expansion
7
Expected
10
Fda
11
Financial
7
Financial results
7
Genetown
7
Global
45
Growing
5
Growth
33
Hormone
7
Insulin
32
Iot
6
Kidney
5
Liver
11
Market
79
Money
8
N/a
518
Obesity
16
People
11
Pharma
81
Pharmaceutical
12
Phase 2
7
Phase 3
6
Program
10
Reach
10
Report
39
Repurchase
97
Research
34
Results
20
S
42
Sales
13
Sanofi
7
Study
6
Technology
10
Therapeutics
27
Therapy
11
Treatment
34
Trial
32
Trials
9
Update
12
Entities
Abbott laboratories
1
Astrazeneca plc
1
Becton, dickinson and company
8
Eli lilly and company
13
Entera bio ltd.
1
Glaxosmithkline plc
1
Insulet corporation
6
Johnson & johnson
1
Lannett co inc
1
Mannkind corporation
1
Medtronic plc
7
Novartis ag
1
Novo nordisk a/s
32
Retractable technologies, inc.
1
Sanofi
13
Terumo corp
3
Viatris inc.
1
Symbols
ABT
10
ACN
1
AKRO
1
ARVL
1
AZN
2
AZNCF
1
BDX
10
BIVI
2
BMEA
5
CRNX
4
DPRO
1
DXCM
4
EIGR
1
EMBC
3
ENTX
1
FNCTF
1
GLAXF
2
GSK
3
GTHX
1
JNJ
6
LCI
8
LLY
37
MDT
21
MNKD
6
MODD
1
NMRD
1
NVO
32
NVS
3
NVSEF
2
ORMP
21
PODD
23
PXMD
1
RAPT
1
RVP
2
RZLT
2
SANA
1
SEOVF
2
SNY
54
SNYNF
41
TNDM
8
TNXP
2
TRUMF
5
TRUMY
5
VTRS
3
VTVT
3
ZEAL
6
ZVSA
1
Exchanges
Amex
1
Nasdaq
17
Nyse
32
Crawled Date
2024 - 03 - 21
1
2024 - 02 - 23
1
2024 - 01 - 08
1
2023 - 09 - 19
1
2023 - 07 - 28
1
2023 - 06 - 25
2
2023 - 06 - 22
1
2023 - 04 - 28
1
2023 - 03 - 14
1
2023 - 03 - 04
1
2023 - 02 - 06
1
2023 - 01 - 04
1
2022 - 12 - 22
1
2022 - 11 - 15
1
2022 - 11 - 07
1
2022 - 10 - 17
1
2022 - 10 - 14
1
2022 - 10 - 03
1
2022 - 09 - 22
1
2022 - 08 - 23
1
2022 - 07 - 29
1
2022 - 06 - 20
1
2022 - 06 - 03
1
2022 - 05 - 02
1
2022 - 04 - 28
1
2022 - 03 - 18
1
2022 - 01 - 03
1
2021 - 12 - 20
1
2021 - 11 - 26
1
2021 - 08 - 18
1
2021 - 06 - 21
1
Crawled Time
00:20
2
04:20
1
07:00
3
08:00
2
10:00
1
12:00
4
12:20
1
13:00
1
14:00
1
14:20
1
15:00
2
15:20
1
16:00
3
17:00
3
18:00
1
19:00
3
20:00
1
21:00
1
Source
www.aspenpharma.com
1
www.biospace.com
2
www.globenewswire.com
9
www.prnewswire.com
20
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
tags :
Insulin
symbols :
Nvo
save search
Awiqli® (once-weekly basal insulin icodec) recommended for approval for the treatment of diabetes by the European regulatory authorities
Published:
2024-03-21
(Crawled : 16:00)
- globenewswire.com
NVO
|
News
|
$125.26
2.08%
0.18%
3.6M
|
Health Technology
|
-3.91%
|
O:
-1.04%
H:
1.6%
C:
0.64%
awiqli
approval
treatment
diabetes
insulin
Insulin Pen Global Market Outlook Report 2024-2028: Current Market Size and Revenue Growth Prospects for Insulin Pens, with Market Share Analysis by Type, Onset Time, End User and Geographical Region
Published:
2024-02-23
(Crawled : 17:00)
- prnewswire.com
NVSEF
|
News
|
$93.6375
6.88%
82K
|
Health Technology
|
-7.54%
|
O:
0.37%
H:
0.58%
C:
0.58%
VTRS
|
News
A
|
$11.235
-0.13%
-0.13%
5.1M
|
Health Technology
|
-15.79%
|
O:
0.0%
H:
1.93%
C:
1.27%
NVO
|
News
|
$125.26
2.08%
0.18%
3.6M
|
Health Technology
|
0.59%
|
O:
-0.68%
H:
0.4%
C:
-0.18%
NVS
|
News
|
$95.12
0.81%
-1.18%
2.4M
|
Health Technology
|
-7.81%
|
O:
0.89%
H:
0.4%
C:
0.17%
JNJ
|
News
|
$149.12
0.82%
0.0%
9.3M
|
Health Technology
|
-7.06%
|
O:
0.28%
H:
0.0%
C:
0.0%
SNY
|
News
|
$47.125
1.78%
1.75%
2.1M
|
Health Technology
|
-3.42%
|
O:
0.97%
H:
0.0%
C:
0.0%
report
revenue
global
insulin
growth
market
COMBINE 3 phase 3a trial successfully completed with once-weekly IcoSema demonstrating non-inferior reduction in HbA1c versus daily basal-bolus treatment (insulin glargine U100 and insulin aspart) in people with type 2 diabetes
Published:
2024-01-08
(Crawled : 13:00)
- globenewswire.com
NVO
|
News
|
$125.26
2.08%
0.18%
3.6M
|
Health Technology
|
18.19%
|
O:
0.19%
H:
0.34%
C:
0.21%
treatment
glargine
trial
diabetes
insulin
Aspen announces contract manufacturing agreement to initiate local production of Human Insulin for Novo Nordisk at its Gqeberha based sterile manufacturing facility
Published:
2023-09-19
(Crawled : 17:00)
- aspenpharma.com
NVO
|
News
|
$125.26
2.08%
0.18%
3.6M
|
Health Technology
|
34.25%
|
O:
-0.56%
H:
1.1%
C:
0.8%
contract
agreement
insulin
Global Insulin Pen Market Projected to Reach $73.39 Billion by 2028 with Steady CAGR of 5.25% during 2023-2028
Published:
2023-07-28
(Crawled : 19:00)
- prnewswire.com
TRUMY
|
$16.43
0.79%
34K
|
Manufacturing
|
Email alert
Add to watchlist
NVO
|
News
|
$125.26
2.08%
0.18%
3.6M
|
Health Technology
|
Email alert
Add to watchlist
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
Email alert
Add to watchlist
LLY
|
News
|
$731.33
0.69%
0.0%
2.3M
|
Health Technology
|
Email alert
Add to watchlist
TRUMF
|
$16.74
-17.59%
1.3K
|
Health Technology
|
Email alert
Add to watchlist
SNY
|
News
|
$47.125
1.78%
1.75%
2.1M
|
Health Technology
|
Email alert
Add to watchlist
reach
global
insulin
market
New data show once-weekly insulin icodec met additional endpoints in adults with type 2 diabetes in phase 3a trials
Published:
2023-06-24
(Crawled : 00:20)
- prnewswire.com
NVO
|
News
|
$125.26
2.08%
0.18%
3.6M
|
Health Technology
|
Email alert
Add to watchlist
trials
diabetes
insulin
show
Novo Nordisk A/S: New data show once-weekly insulin icodec met additional endpoints in adults with type 2 diabetes in phase 3a trials
Published:
2023-06-24
(Crawled : 00:20)
- globenewswire.com
NVO
|
News
|
$125.26
2.08%
0.18%
3.6M
|
Health Technology
|
Email alert
Add to watchlist
trials
diabetes
insulin
show
Beta Bionics Announces FDA Clearance for the Use of a Prefilled Insulin Cartridge With the iLet Bionic Pancreas
Published:
2023-06-22
(Crawled : 14:00)
- biospace.com/
NVO
|
News
|
$125.26
2.08%
0.18%
3.6M
|
Health Technology
|
-21.98%
|
O:
-0.45%
H:
0.89%
C:
0.13%
fda
pancreas
clearance
insulin
USD 5.81 Billion Growth in Insulin Biosimilars Market Size - Industry Analysis, Market Trends, Market Growth, Opportunities
Published:
2023-04-28
(Crawled : 15:20)
- prnewswire.com
NVO
|
News
|
$125.26
2.08%
0.18%
3.6M
|
Health Technology
|
-24.55%
|
O:
0.22%
H:
1.02%
C:
0.42%
insulin
growth
market
Novo Nordisk to lower U.S. prices of several pre-filled insulin pens and vials up to 75% for people living with diabetes in January 2024
Published:
2023-03-14
(Crawled : 19:00)
- biospace.com/
NVO
|
News
|
$125.26
2.08%
0.18%
3.6M
|
Health Technology
|
-10.87%
|
O:
1.15%
H:
0.65%
C:
0.56%
diabetes
living
insulin
Insulin Pump Market - Global Outlook and Forecast 2023-2028: New Product Launches and Technological Advances in Diabetes Care Present Opportunities
Published:
2023-03-04
(Crawled : 04:20)
- prnewswire.com
PODD
|
$164.46
-1.08%
-1.09%
680K
|
Health Technology
|
Email alert
Add to watchlist
NVO
|
News
|
$125.26
2.08%
0.18%
3.6M
|
Health Technology
|
Email alert
Add to watchlist
care
global
diabetes
insulin
market
Smart Insulin Pens Market Size to Reach USD 302.1 Million in 2030 | Emergen Research
Published:
2023-02-06
(Crawled : 18:00)
- prnewswire.com
NVO
|
News
|
$125.26
2.08%
0.18%
3.6M
|
Health Technology
|
-8.43%
|
O:
0.61%
H:
0.88%
C:
0.33%
MDT
|
$80.57
1.37%
0.0%
5M
|
Health Technology
|
-7.5%
|
O:
-0.31%
H:
0.08%
C:
-1.83%
LLY
|
News
|
$731.33
0.69%
0.0%
2.3M
|
Health Technology
|
115.68%
|
O:
0.86%
H:
0.42%
C:
-1.26%
SNY
|
News
|
$47.125
1.78%
1.75%
2.1M
|
Health Technology
|
0.75%
|
O:
-0.84%
H:
0.0%
C:
0.0%
research
smart
insulin
market
LANNETT PROVIDES DEVELOPMENT UPDATE ON BIOSIMILAR INSULIN PRODUCTS
Published:
2023-01-04
(Crawled : 12:00)
- prnewswire.com
NVO
|
News
|
$125.26
2.08%
0.18%
3.6M
|
Health Technology
|
-8.54%
|
O:
1.24%
H:
0.01%
C:
-1.36%
biosimilar
update
insulin
Global Insulin Pen Market Analysis & Forecasts, 2021-2022 & 2023-2027: Focus on United States, India, China, Brazil, Saudi Arabia, United Kingdom, Germany, Netherlands, Sweden, Switzerland, Australia
Published:
2022-12-22
(Crawled : 20:00)
- prnewswire.com
TRUMF
|
$16.74
-17.59%
1.3K
|
Health Technology
|
-40.15%
|
O:
3.99%
H:
0.0%
C:
-0.64%
TRUMY
|
$16.43
0.79%
34K
|
Manufacturing
|
-40.42%
|
O:
-1.16%
H:
2.28%
C:
1.1%
NVO
|
News
|
$125.26
2.08%
0.18%
3.6M
|
Health Technology
|
-6.26%
|
O:
-0.04%
H:
0.33%
C:
0.33%
LLY
|
News
|
$731.33
0.69%
0.0%
2.3M
|
Health Technology
|
100.19%
|
O:
-0.13%
H:
0.84%
C:
0.84%
global
australia
insulin
market
Human Insulin Market is expected to generate a revenue of USD 63.64 Billion by 2028, Globally, at 7.65% CAGR: Verified Market Research®
Published:
2022-11-15
(Crawled : 17:00)
- prnewswire.com
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
5.1%
|
O:
-0.27%
H:
0.0%
C:
0.0%
NVO
|
News
|
$125.26
2.08%
0.18%
3.6M
|
Health Technology
|
9.46%
|
O:
-0.59%
H:
0.37%
C:
-0.1%
LLY
|
News
|
$731.33
0.69%
0.0%
2.3M
|
Health Technology
|
105.4%
|
O:
0.25%
H:
0.01%
C:
-1.96%
BDX
|
$233.88
-0.1%
0.0%
770K
|
Health Technology
|
4.34%
|
O:
0.92%
H:
0.0%
C:
-1.71%
SNY
|
News
|
$47.125
1.78%
1.75%
2.1M
|
Health Technology
|
6.61%
|
O:
1.37%
H:
0.0%
C:
0.0%
research
expected
insulin
market
Insulin Market is Likely to Upsurge USD 25.12 Billion Globally by 2029, Size, Share, Trends, Demand, Market Dynamics, Growth Forecast and Challenges
Published:
2022-11-07
(Crawled : 10:00)
- prnewswire.com
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
6.43%
|
O:
-2.01%
H:
0.88%
C:
0.88%
NVO
|
News
|
$125.26
2.08%
0.18%
3.6M
|
Health Technology
|
11.43%
|
O:
0.91%
H:
1.82%
C:
1.43%
LLY
|
News
|
$731.33
0.69%
0.0%
2.3M
|
Health Technology
|
104.62%
|
O:
0.17%
H:
2.51%
C:
1.97%
SNY
|
News
|
$47.125
1.78%
1.75%
2.1M
|
Health Technology
|
6.87%
|
O:
-0.46%
H:
0.0%
C:
0.0%
insulin
growth
market
Global Insulin Delivery Devices Market Report 2022-2030: Growing Diabetic Population & Surge in the Launch of Insulin Delivery Devices
Published:
2022-10-17
(Crawled : 16:00)
- prnewswire.com
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
14.71%
|
O:
0.67%
H:
0.0%
C:
0.0%
NVO
|
News
|
$125.26
2.08%
0.18%
3.6M
|
Health Technology
|
20.67%
|
O:
1.18%
H:
1.26%
C:
0.93%
MDT
|
$80.57
1.37%
0.0%
5M
|
Health Technology
|
-1.27%
|
O:
1.46%
H:
0.94%
C:
-0.05%
LLY
|
News
|
$731.33
0.69%
0.0%
2.3M
|
Health Technology
|
120.69%
|
O:
0.42%
H:
1.44%
C:
-0.01%
BDX
|
$233.88
-0.1%
0.0%
770K
|
Health Technology
|
4.09%
|
O:
0.74%
H:
1.69%
C:
1.18%
SNY
|
News
|
$47.125
1.78%
1.75%
2.1M
|
Health Technology
|
15.76%
|
O:
0.51%
H:
0.95%
C:
0.65%
PODD
|
$164.46
-1.08%
-1.09%
680K
|
Health Technology
|
-25.64%
|
O:
-0.52%
H:
4.35%
C:
1.9%
global
report
growing
insulin
market
diabetic
Oral Biologics & Biosimilars Global Market Report 2022: Drive to Create Insulin Biosimilars Presents Opportunities
Published:
2022-10-14
(Crawled : 12:00)
- prnewswire.com
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
22.68%
|
O:
6.95%
H:
0.0%
C:
0.0%
AZNCF
|
News
|
$136.2
-4.19%
1.7K
|
Health Technology
|
28.93%
|
O:
1.95%
H:
1.5%
C:
1.5%
NVO
|
News
|
$125.26
2.08%
0.18%
3.6M
|
Health Technology
|
19.49%
|
O:
0.03%
H:
0.35%
C:
-1.01%
GSK
|
News
|
$40.59
2.11%
-0.36%
3.8M
|
Health Technology
|
32.43%
|
O:
0.59%
H:
0.66%
C:
-0.39%
SNY
|
News
|
$47.125
1.78%
1.75%
2.1M
|
Health Technology
|
18.93%
|
O:
2.74%
H:
0.0%
C:
0.0%
ENTX
|
$2.1
5.53%
5.24%
170K
|
Health Technology
|
135.44%
|
O:
1.06%
H:
0.01%
C:
-4.53%
AZN
|
News
|
$70.12
2.29%
2.24%
4.8M
|
Health Technology
|
26.29%
|
O:
1.22%
H:
0.52%
C:
-2.21%
RVP
P
|
$1.07
0.94%
0.94%
22K
|
Health Technology
|
-44.56%
|
O:
-1.55%
H:
8.42%
C:
5.26%
global
report
insulin
market
Once-weekly insulin icodec demonstrates superior reduction in HbA1c in combination with a dosing guide app versus once-daily basal insulin in people with type 2 diabetes in ONWARDS 5 phase 3a trial
Published:
2022-10-03
(Crawled : 12:20)
- globenewswire.com
NVO
|
News
|
$125.26
2.08%
0.18%
3.6M
|
Health Technology
|
25.73%
|
O:
1.98%
H:
1.29%
C:
0.94%
trial
diabetes
insulin
More people with type 2 diabetes achieved blood sugar target with once-weekly insulin icodec compared with once-daily insulin degludec
Published:
2022-09-22
(Crawled : 07:00)
- globenewswire.com
NVO
|
News
|
$125.26
2.08%
0.18%
3.6M
|
Health Technology
|
26.24%
|
O:
-0.44%
H:
0.38%
C:
-0.48%
blood
diabetes
insulin
← Previous
1
2
Next →
Gainers vs Losers
75%
25%
Top 10 Gainers
MTTR
|
News
M
|
$4.78
174.71%
63.6%
72M
|
AGBA
|
$2.565
105.2%
51.27%
200M
|
Finance
MLEC
|
$2.44
74.29%
42.62%
78M
|
n/a
EDBL
|
News
|
$6.28
67.02%
40.13%
16M
|
ATGL
|
$2.91
48.81%
32.8%
180K
|
ZAPP
|
$0.2175
47.16%
32.05%
16M
|
n/a
ONFO
|
$0.6075
38.38%
27.74%
7.3M
|
n/a
VIVK
|
$1.48
38.32%
27.7%
530K
|
Professional, Scientific, and T...
MNTS
|
$0.5
35.69%
26.3%
4.8M
|
SDIG
A
|
$3.635
35.13%
26.0%
1M
|
Your saved searches
Save your searches and get alerts when important news are released.